Aravive And AGBA Acquisition Limited On The List Of Winners And Losers Of Friday’s US Session

(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the US session. The three biggest winners today are Aravive, Senmiao Technology Limited, and Amicus Therapeutics. Rank Financial Asset Price Change Updated (EST) 1 Aravive (ARAV) 0.21 45.67% 2023-10-20 10:41:06 2 Senmiao Technology Limited…

Read More

Inovio Pharmaceuticals Soars Over 27% In 10 Sessions: Is It Time To Invest?

(VIANEWS) – Inovio Pharmaceuticals (NASDAQ: INO) stock experienced an incredible 27.78% gain over just 10 sessions, going from EUR0.36 on October 5th to EUR0.46 at 18:22 EST on Thursday afternoon – an enthralling turnaround after two consecutive losses on NASDAQ. INO’s impressive performance stood out, especially against an overall market decline with EUR13,186.18 down 0.96%…

Read More

Inovio Pharmaceuticals Stock Soars 32% In 21 Sessions: What’s Driving The Surge?

(VIANEWS) – Inovio Pharmaceuticals (INO) shares have seen their value grow by 32.5% in 21 sessions, from EUR0.4 to EUR0.53. This surge followed an upward trend seen during previous sessions and despite overall decrease of 0.04% on the NASDAQ which currently stands at EUR13,562.15, Inovio Pharmaceuticals continues to perform strongly; their last closing price stood…

Read More

Inovio Pharmaceuticals Soars 30% In 10 Sessions: What’s Driving The Stock?

(VIANEWS) – Inovio Pharmaceuticals Stock Soars by 30.77% Over 10 Sessions Inovio Pharmaceuticals (NASDAQ: INO) shares saw an astounding 30.77% gain over just 10 sessions, rising from EUR0.39 on September 29 to EUR0.51 by Friday 18:31 EST at 18:31 EST despite experiencing a significant downward trend during earlier sessions. This significant jump followed a downward…

Read More

Inovio Pharmaceuticals And Groupon On The List Of Winners And Losers Of Tuesday’s US Session

(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the US session. The three biggest winners today are Inovio Pharmaceuticals, Gevo, and Virgin Galactic. Rank Financial Asset Price Change Updated (EST) 1 Inovio Pharmaceuticals (INO) 0.50 39.97% 2023-10-10 12:13:09 2 Gevo (GEVO) 1.15…

Read More

Less Than One Hour Before The NASDAQ Open, Inovio Pharmaceuticals Is Up By 4%

(VIANEWS) – The NASDAQ opens in less than one hour and Inovio Pharmaceuticals‘s pre-market value is already 4.48% up. Inovio Pharmaceuticals’s last close was $0.40, 84.67% below its 52-week high of $2.61. The last session, NASDAQ ended with Inovio Pharmaceuticals (INO) rising 0.5% to $0.40. NASDAQ jumped 0.01% to $13,710.24, following the last session’s upward…

Read More

MPLX LP And Enbridge On The List Of Winners And Losers Of Wednesday’s US Premarket Session

(VIANEWS) – Good morning! Another day of trading is almost starting and here’s today’s list of stocks that have had significant trading activity in the US premarket session. The three biggest winners today are MPLX LP, Cronos Group, and Ambev. Rank Financial Asset Price PremarketChange Updated (EST) 1 MPLX LP (MPLX) 34.93 0.06% 2023-09-06 06:32:55…

Read More

Bionano Genomics And ANGI Homeservices On The List Of Winners And Losers Of Thursday’s US Session

(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the US session. The three biggest winners today are Bionano Genomics, Inovio Pharmaceuticals, and Lumen Technologies. Rank Financial Asset Price Change Updated (EST) 1 Bionano Genomics (BNGOW) 0.01 24.59% 2023-08-10 10:44:07 2 Inovio Pharmaceuticals…

Read More

Inovio Pharmaceuticals Stock Is 11% Up So Far On Thursday

Inovio Pharmaceuticals (NASDAQ: INO) experienced a significant stock increase of 11.91% to $7.45 last Thursday. This resurgence came after five consecutive trading losses coinciding with a minor 0.5% NASDAQ uplift to $13,729.12, potentially signaling a shift towards bullish market conditions. Company’s Performance The biotechnology company, specializing in the creation and commercialization of DNA medicines for…

Read More